Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implications of the 375W mutation for HIV-1 tropism and vaccine development.

Journal of virology·2024
Same author

No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complications.

Archives of virology·2018
Same author

Ultradeep single-molecule real-time sequencing of HIV envelope reveals complete compartmentalization of highly macrophage-tropic R5 proviral variants in brain and CXCR4-using variants in immune and peripheral tissues.

Journal of neurovirology·2018
Same author

HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.

Journal of virology·2017
Same author

Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.

Journal of virology·2017
Same author

Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.

PLoS pathogens·2017

Related Experiment Video

Updated: Jun 28, 2026

Surgical Implant Procedure and Wiring Configuration for Continuous Long-Term EEG/ECG Monitoring in Rabbits
08:36

Surgical Implant Procedure and Wiring Configuration for Continuous Long-Term EEG/ECG Monitoring in Rabbits

Published on: January 24, 2025

Plugging gp120s cavity.

Alexander Repik1, Paul R Clapham

  • 1Program in Molecular Medicine and Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Structure (London, England : 1993)
|November 13, 2008
PubMed
Summary
This summary is machine-generated.

NBD-556, an HIV-1 entry inhibitor, binds to the conserved Phe-43 cavity on the HIV-1 gp120 surface glycoprotein. This binding induces conformational changes similar to those caused by CD4 binding, offering a new target for HIV-1 therapies.

More Related Videos

Assembly and Characterization of an External Driver for the Generation of Sub-Kilohertz Oscillatory Flow in Microchannels
08:32

Assembly and Characterization of an External Driver for the Generation of Sub-Kilohertz Oscillatory Flow in Microchannels

Published on: January 28, 2022

A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways
09:39

A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways

Published on: May 9, 2016

Related Experiment Videos

Last Updated: Jun 28, 2026

Surgical Implant Procedure and Wiring Configuration for Continuous Long-Term EEG/ECG Monitoring in Rabbits
08:36

Surgical Implant Procedure and Wiring Configuration for Continuous Long-Term EEG/ECG Monitoring in Rabbits

Published on: January 24, 2025

Assembly and Characterization of an External Driver for the Generation of Sub-Kilohertz Oscillatory Flow in Microchannels
08:32

Assembly and Characterization of an External Driver for the Generation of Sub-Kilohertz Oscillatory Flow in Microchannels

Published on: January 28, 2022

A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways
09:39

A Microfluidic Model of Biomimetically Breathing Pulmonary Acinar Airways

Published on: May 9, 2016

Area of Science:

  • Virology
  • Structural Biology
  • Drug Discovery

Background:

  • HIV-1 entry inhibitors are crucial for antiretroviral therapy.
  • The HIV-1 surface glycoprotein gp120 mediates viral entry by binding to the CD4 receptor.
  • Understanding gp120 conformational changes is key to developing novel inhibitors.

Purpose of the Study:

  • To investigate the binding site and mechanism of action of NBD-556, a novel HIV-1 entry inhibitor.
  • To elucidate the structural basis of NBD-556's interaction with HIV-1 gp120.
  • To explore the potential of targeting the Phe-43 cavity for HIV-1 entry inhibition.

Main Methods:

  • * Molecular modeling and structural analysis.
  • * Binding assays to determine NBD-556 affinity for gp120.
  • * Conformational analysis of gp120 upon NBD-556 binding.

Main Results:

  • * NBD-556 binds to the highly conserved Phe-43 cavity within the gp120 structure.
  • * This binding event induces conformational changes in gp120.
  • The induced conformational changes mimic those observed upon CD4 binding to gp120.

Conclusions:

  • * The Phe-43 cavity represents a novel and conserved binding site for HIV-1 entry inhibitors.
  • * NBD-556's mechanism involves inducing functional conformational changes in gp120.
  • Targeting the Phe-43 cavity offers a promising strategy for developing next-generation HIV-1 entry inhibitors.